TrianglePUBLICATIONS · 32109194
Randomized Phase II Study of First-Line Cladribine With Concurrent or Delayed Rituximab in Patients With Hairy Cell Leukemia.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2020 May 10
- First author
- Chihara D
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Chihara D
- type
- Author
- name
- Arons E
- type
- Author
- name
- Stetler-Stevenson M
- type
- Author
- name
- Yuan CM
- type
- Author
- name
- Wang HW
- type
- Author
- name
- Zhou H
- type
- Author
- name
- Raffeld M
- type
- Author
- name
- Xi L
- type
- Author
- name
- Steinberg SM
- type
- Author
- name
- Feurtado J
- type
- Author
- name
- James L
- type
- Author
- name
- Wilson W
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Chihara D
- type
- Author
- name
- Arons E
- type
- Author
- name
- Stetler-Stevenson M
- type
- Author
- name
- Yuan CM
- type
- Author
- name
- Wang HW
- type
- Author
- name
- Zhou H
- type
- Author
- name
- Raffeld M
- type
- Author
- name
- Xi L
- type
- Author
- name
- Steinberg SM
- type
- Author
- name
- Feurtado J
- type
- Author
- name
- James L
- type
- Author
- name
- Wilson W
- type
- Author
- bibliography ids
- nci-bib-af74298c808d098abfded086
- book metadata
- content sha256
- 67536e1fdb616f7e4c1cb9eb274dffc87f1fcdd713d6ddcfa12b7599d26d33f9
- document type
- citation
- dois
- 10.1200/JCO.19.02250
- electronic publication date
- display
- 2020 Feb 28
- precision
- day
- year
- 2020
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:32109194
- immutable id
- pubmed:32109194@67536e1fdb616f7e4c1cb9eb274dffc87f1fcdd713d6ddcfa12b7599d26d33f9
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 14
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 1527-1538
- volume
- 38
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 32109194
- provenance
- batch id
- 4c5003fbb78890e89ae1
- provider
- NCBI PubMed ESummary
- record sha256
- 5007372d5afcf12553d0acf43ed9c0d5e6062a630ad7690e1e24b512e0fae75c
- response sha256
- 890389583ce193a9c74e19c63678e418dad2088e82cb704b888b02fcc887d269
- retrieved at
- 2026-09-09T23:47:48.270700+00:00
- publication date
- display
- 2020 May 10
- precision
- day
- year
- 2020
- publication types
- Clinical Trial, Phase II
- Journal Article
- Randomized Controlled Trial
- Research Support, N.I.H., Intramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Randomized Phase II Study of First-Line Cladribine With Concurrent or Delayed Rituximab in Patients With Hairy Cell Leukemia.
Preserved source evidence · Not medical advice